Longdom Conferences, a global leader in organizing over 200 international conferences and virtual events annually, proudly presents the 12th World Congress on Heart and Cardiovascular Diseases, scheduled for August 17–18, 2026, at 09:30 AM in Toronto, Canada. In response to the rising global burden of cardiovascular diseases and rapid advancements in cardiology, this prestigious congress is organized under the theme “Innovating Cardiovascular Care for Healthier Hearts Worldwide.” The conference aims to engage, empower, evolve, and explore knowledge across all levels of cardiovascular research and clinical practice, bringing together cardiologists, researchers, clinicians, academicians, and industry experts from across the globe. By highlighting core concepts alongside major breakthroughs in emerging areas of cardiovascular medicine, the congress provides a dynamic platform for scientific exchange, collaboration, and innovation, ultimately contributing to improved heart health and better patient outcomes worldwide.

Why to Attend?

Participating in the 12th World Congress on Heart and Cardiovascular Diseases offers an exceptional opportunity for professionals involved in cardiology and cardiovascular healthcare to:

Gain in-depth insights into the latest research findings, clinical advancements, and innovative treatment strategies in cardiovascular medicine.
Explore cutting-edge technologies, including digital health solutions and AI-driven diagnostics, shaping the future of heart care.
Network with leading cardiologists, researchers, surgeons, healthcare professionals, and industry leaders from across the globe.
Earn continuing education credits while enhancing clinical expertise and professional development.
Engage in high-impact scientific discussions, interactive sessions, and collaborative workshops that inspire innovation and knowledge exchange.
Stay ahead of emerging trends, evolving guidelines, and best practices in the prevention, diagnosis, and management of cardiovascular diseases.

Target Audience
Cardiologists and Interventional Cardiologists
Cardiovascular and Cardiothoracic Surgeons
Physicians and Internal Medicine Specialists
Clinical and Translational Researchers
Academicians and Medical Faculty
Nurses and Cardiac Care Professionals
Allied Health Professionals and Technicians
Healthcare Administrators and Policy Makers
Medical Device and Pharmaceutical Industry Professionals
Digital Health, AI, and Health Technology Experts
Public Health Professionals and Epidemiologists
Students, Residents, Fellows, and Postgraduate Scholars
Researchers and Professionals in Preventive Cardiology

Sessions and Tracks

Track 1: Advanced Cardiac Diagnostics and Imaging

This track focuses on the latest developments in clinical cardiology and cutting-edge cardiac imaging techniques. It covers innovations in echocardiography, cardiac MRI, CT angiography, and nuclear cardiology, emphasizing accurate diagnosis, risk assessment, and personalized patient care. Attendees will explore how advanced imaging technologies, combined with clinical expertise, are transforming cardiovascular diagnostics and enabling timely, effective treatment strategies.

Track 2: Cardiac Electrophysiology

This track focuses on the study, diagnosis, and management of cardiac arrhythmias, encompassing both common and complex heart rhythm disorders. It highlights advances in electrophysiological techniques, including catheter ablation, pacemaker and defibrillator therapies, and emerging technologies for rhythm monitoring. Attendees will gain insights into mechanisms of arrhythmias, innovative treatment strategies, and the role of digital tools and AI in improving patient outcomes in cardiac electrophysiology.

Track 3: Heart Health & Fitness

This track emphasizes the critical role of lifestyle, exercise, and nutrition in maintaining cardiovascular health and preventing heart diseases. It explores evidence-based strategies for physical activity, dietary interventions, weight management, and stress reduction to enhance heart function and overall wellness. Attendees will learn about practical approaches to lifestyle modification, preventive cardiology, and patient-centered programs that promote long-term cardiovascular health.

Track 4: Peripheral Artery Disease

This track focuses on the prevention, diagnosis, and management of peripheral artery disease (PAD), a common circulatory condition characterized by narrowed arteries that reduce blood flow to the limbs. Topics include the latest advancements in vascular imaging, minimally invasive interventions, pharmacological therapies, and lifestyle modifications to improve patient outcomes. Attendees will gain insights into risk assessment, early detection strategies, and multidisciplinary approaches for managing PAD and associated cardiovascular complications.

Track 5: Heart Failure Management

This track focuses on the latest advancements in the diagnosis, treatment, and management of heart failure. It covers innovative therapeutic strategies, including pharmacological treatments, device-based interventions, lifestyle modifications, and emerging regenerative therapies. Attendees will gain insights into improving patient outcomes, managing chronic heart conditions, and integrating multidisciplinary approaches for effective heart failure care.

Track 6: Clinical Cardiology

This track focuses on the comprehensive evaluation, diagnosis, and management of patients with cardiovascular diseases. It encompasses advances in clinical assessment, risk stratification, preventive cardiology, and evidence-based treatment strategies. Attendees will explore the integration of modern diagnostic tools, patient-centered care approaches, and emerging therapies to improve cardiovascular outcomes and enhance overall heart health.

Track 7: Cardiac Risk Prevention

This track focuses on strategies to identify, assess, and reduce risk factors for cardiovascular diseases. It covers preventive approaches including lifestyle modification, nutrition, exercise, early detection of hypertension, diabetes, and dyslipidemia, as well as pharmacological interventions. Attendees will learn about evidence-based practices, risk stratification tools, and public health initiatives aimed at lowering the incidence of heart disease and promoting long-term cardiovascular wellness.

Track 8: AI in Cardiology

This track explores the transformative role of artificial intelligence (AI) and machine learning in cardiovascular medicine. It covers AI applications in cardiac imaging, diagnostics, risk prediction, patient monitoring, and personalized treatment planning. Attendees will gain insights into how AI-driven tools are enhancing clinical decision-making, improving accuracy, reducing diagnostic errors, and optimizing patient outcomes in cardiology. The track also highlights future trends, challenges, and ethical considerations in integrating AI into cardiovascular care.

Track 9: Personalized Cardiovascular Medicine

This track focuses on the integration of genetic insights, biomarker analysis, and precision medicine approaches to tailor cardiovascular care for individual patients. It covers advances in genomic testing, pharmacogenomics, risk stratification, and personalized therapeutic strategies. Attendees will explore how personalized medicine is transforming the prevention, diagnosis, and treatment of heart diseases, improving patient outcomes, and supporting more targeted, effective, and patient-centered cardiovascular care.

Track 10: Digital Cardiac Care

This track explores the impact of digital health technologies and telemedicine on cardiovascular care. It highlights innovations such as remote patient monitoring, wearable devices, mobile health applications, teleconsultations, and AI-driven digital platforms that improve diagnosis, treatment, and patient engagement. Attendees will learn how digital solutions enhance access to care, enable real-time monitoring, support personalized treatment plans, and contribute to better outcomes in cardiology.

Track 11: Advances in General Cardiology

This track focuses on the latest developments and innovations in general cardiology, encompassing the prevention, diagnosis, and management of cardiovascular diseases. It covers emerging therapies, clinical guidelines, risk factor modification, and integrated approaches to improve patient outcomes. Attendees will gain insights into contemporary cardiovascular care, evidence-based practices, and multidisciplinary strategies to address a broad spectrum of heart conditions.

Track 12: Vascular Health & Hypertension

This track focuses on the prevention, diagnosis, and management of hypertension and vascular disorders. It covers advances in blood pressure monitoring, vascular imaging, pharmacological and non-pharmacological therapies, and lifestyle interventions. Attendees will explore strategies to reduce cardiovascular risk, improve vascular function, and manage associated complications such as stroke, heart attack, and kidney disease, emphasizing an integrated approach to vascular and heart health.

Track 13: Fetal and Neonatal Cardiology

This track focuses on the diagnosis, management, and treatment of congenital heart diseases and cardiovascular conditions in fetuses and newborns. It covers advances in prenatal screening, fetal echocardiography, neonatal cardiac care, and surgical interventions for congenital defects. Attendees will gain insights into early detection, risk assessment, and multidisciplinary approaches to optimize outcomes for both mothers and infants, emphasizing innovative strategies in pediatric and neonatal cardiology.

Track 14: Novel Heart Treatments

This track highlights the latest advancements in therapeutic approaches and drug development for cardiovascular diseases. It covers innovative pharmacological therapies, biologics, gene-based treatments, and emerging interventions aimed at improving patient outcomes. Attendees will explore clinical trials, translational research, and cutting-edge strategies that are shaping the future of cardiovascular care, focusing on efficacy, safety, and personalized treatment approaches.

Track 15: Heart Disease in Women

This track focuses on the unique aspects of cardiovascular disease in women, including gender-specific risk factors, presentation patterns, diagnostics, and treatment strategies. It covers conditions such as coronary artery disease, heart failure, arrhythmias, and pregnancy-related cardiac complications. Attendees will gain insights into preventive measures, early detection, and personalized management approaches that address the physiological and hormonal differences affecting women’s heart health.

Track 16: Cardio-Oncology

This track focuses on the intersection of cardiology and oncology, addressing cardiovascular complications related to cancer and its treatments. It covers the detection, prevention, and management of cardiotoxicity caused by chemotherapy, radiotherapy, and targeted therapies. Attendees will explore strategies for risk assessment, monitoring, and multidisciplinary approaches to optimize cardiovascular health in cancer patients, ensuring safe and effective cancer treatment while protecting heart function.

Track 17: Cardiac Transplantation

This track focuses on heart transplantation and mechanical circulatory support for patients with end-stage heart failure. It covers donor selection, surgical techniques, post-transplant care, immunosuppressive therapies, and long-term management strategies. Attendees will also explore ventricular assist devices (VADs), ECMO, and other mechanical support options as bridges to transplant or destination therapy, emphasizing multidisciplinary approaches to optimize patient outcomes and survival.

Track 18: Heart Rehabilitation

This track focuses on comprehensive cardiac rehabilitation programs designed to improve recovery, physical fitness, and overall cardiovascular health after heart disease, surgery, or intervention. It covers exercise training, nutritional guidance, stress management, lifestyle modification, and patient education. Attendees will gain insights into multidisciplinary approaches that enhance functional capacity, reduce recurrence of cardiac events, and improve quality of life for patients with cardiovascular conditions.

Track 19: Congenital Heart Diseases

This track focuses on the diagnosis, management, and treatment of congenital heart diseases (CHDs) in infants, children, and adults. It covers prenatal detection, pediatric cardiac interventions, surgical and minimally invasive procedures, and long-term follow-up care. Attendees will explore advances in imaging, genetics, and multidisciplinary approaches that improve survival, quality of life, and outcomes for patients with congenital heart defects.

Track 20: Echocardiography & MRI

This track focuses on advanced cardiac imaging techniques, including echocardiography and cardiac magnetic resonance imaging (MRI), for accurate diagnosis and assessment of heart diseases. It covers structural and functional evaluation, detection of cardiac abnormalities, risk assessment, and guidance for interventional procedures. Attendees will gain insights into the latest technological advancements, imaging protocols, and applications in both clinical practice and research to improve patient outcomes.

Benefits of Participation

Benefits for Speakers

Publication of all accepted abstracts in relevant peer-reviewed cardiovascular journals.
CPD credits and official participation certificates for speakers and attendees.
Global visibility for your research among leading cardiologists, cardiovascular researchers, and healthcare professionals.
Opportunities for career growth and professional advancement in the field of cardiology.
Access to the latest breakthroughs and innovations in cardiovascular medicine, diagnostics, and therapeutics.
Build meaningful, long-term collaborations and networks through high-impact sessions and workshops.
Promote your research through conference abstract books and promotional materials, with exposure to a global audience of cardiovascular experts.
Explore interdisciplinary topics beyond your core area, including preventive cardiology, digital health, regenerative medicine, AI in cardiology, and advanced surgical interventions.

Benefits for Delegates

Expand your knowledge and enhance your professional expertise in cardiology and cardiovascular care.
Reignite your passion and motivation through engaging scientific sessions, keynote lectures, and interactive workshops.
Discover and explore innovative approaches that aim to improve cardiovascular health and patient outcomes.
Connect and network with leading cardiologists, cardiovascular surgeons, researchers, and healthcare professionals from around the world.
Gain insights into cutting-edge technologies, preventive strategies, and emerging therapies shaping the future of cardiovascular medicine.

Benefits for Sponsors

Showcase your brand and products to a global audience of cardiovascular experts, clinicians, and industry leaders.
Build strategic partnerships and expand business opportunities in the field of cardiology and cardiovascular care.
Gain visibility through sponsorship opportunities, including logo placement, exhibition booths, and promotional materials.
Engage directly with key decision-makers and potential clients during networking sessions and workshops.
Promote innovative solutions, medical devices, and pharmaceutical products to enhance cardiovascular health worldwide.

Elite Sponsor Benefits

Opportunity to sponsor 10 Poster Presentation Awards at the Heart and Cardiovascular Diseases Congress.
Three corporate-sponsored workshop slots with full audio-visual support included.
Two complementary exhibition booths (3×3 sqm) with priority location selection.
Four complimentary conference registrations for sponsor representatives.
Prominent logo visibility on the congress website homepage, sponsorship page, and associated cardiovascular journal platforms.
One full-page colour advertisement in the congress program or abstract book (excluding cover pages).
Three promotional inserts supplied by the sponsor included in delegate bags.
One post-conference email campaign to registered attendees (within 60 days, sponsor content subject to approval).
Exclusive online promotion across official social media channels.
Enjoy a 20% discount on sponsorship for any future conference organized next year.

Gold Sponsor Benefits

Opportunity to sponsor 5 Poster Presentation Awards at the congress.
Two corporate-sponsored workshop slots, including catering and full audio-visual support (subject to deadline adherence).
One complimentary exhibition booth (3×3 sqm) with priority location selection.
Three complimentary congress registrations for sponsor representatives.
Prominent logo visibility on the congress website homepage and sponsorship page.
One full-page color advertisement in the congress program or abstract book (excluding cover pages).
Two promotional inserts supplied by the sponsor included in delegate bags.
Exclusive online promotion across official social media platforms.
Receive a 15% discount on sponsorship for any future conference organized next year.

Silver Sponsor Benefits

Opportunity to sponsor 3 Poster Presentation Awards at the congress.
Two complimentary congress registrations for sponsor representatives.
One corporate-sponsored workshop slot, including catering and full audio-visual support (subject to deadline adherence).
One complimentary exhibition booth (3×3 sqm) with priority location selection.
Logo visibility on the congress sponsorship page of the official website.
One full-page colour advertisement in the congress program or book of abstracts (excluding cover pages).
One promotional insert was supplied by the sponsor and included in delegate bags.
Priority access to purchase additional sponsorship opportunities.
Exclusive online promotion across all official social media platforms.
Enjoy a 10% discount on sponsorship for any future conference organized next year.

Market Analysis Report

The global cardiovascular market is experiencing robust growth, driven by rising prevalence of heart diseases, aging populations, and technological advancements. The cardiovascular treatment market is valued at approximately USD 241.18 billion in 2024 and is projected to reach USD 383.11 billion by 2033 at a CAGR of ~5.1 %, while the cardiovascular devices market is expected to grow from USD 53.7 billion in 2024 to USD 106.7 billion by 2033 (~7.8 % CAGR). The cardiovascular drugs market is forecasted to expand from around USD 155.96 billion in 2025 to USD 214.72 billion by 2034 (~3.62 % CAGR), and digital cardiology solutions, including AI and remote monitoring, are projected to grow from USD 1.35 billion in 2024 to USD 3.26 billion by 2034 (~9.22 % CAGR). These trends reflect increasing demand for innovative diagnostics, minimally invasive interventions, preventive strategies, and personalized care, highlighting significant opportunities for collaboration, research dissemination, and business growth, making the 12th World Congress on Heart and Cardiovascular Diseases an ideal platform to engage global stakeholders and showcase cutting-edge advancements in cardiology.

Abstracts enquiry

Registration enquiry

Contact Enquiry

Phone

WhatsApp

Useful Links

News

Newsletter

About

Heart and Cardiovascular Diseases